Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 03:13:07 +0200Thu, 22 Feb 2024 10:15:00 +0100Human medicines European public assessment report (EPAR): Herceptin, trastuzumab, Date of authorisation: 28/08/2000, Revision: 43, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/herceptinHuman medicines European public assessment report (EPAR): Herceptin, trastuzumab, Date of authorisation: 28/08/2000, Revision: 43, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/herceptinThu, 22 Feb 2024 10:15:00 +0100Human medicineHerceptin : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/wc500049815_en.pdfHerceptin : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/wc500049815_en.pdfWed, 19 Apr 2017 02:09:21 +0200Human medicine